Literature DB >> 10329657

The role of amino acids in extracellular loops of the human P2Y1 receptor in surface expression and activation processes.

C Hoffmann1, S Moro, R A Nicholas, T K Harden, K A Jacobson.   

Abstract

The P2Y1 receptor is a membrane-bound G protein-coupled receptor stimulated by adenine nucleotides. Using alanine scanning mutagenesis, the role in receptor activation of charged amino acids (Asp, Glu, Lys, and Arg) and cysteines in the extracellular loops (EL) of the human P2Y1 receptor has been investigated. The mutant receptors were expressed in COS-7 cells and measured for stimulation of phospholipase C induced by the potent agonist 2-methylthioadenosine-5'-diphosphate (2-MeSADP). In addition to single point mutations, all receptors carried the hemagglutinin epitope at the N- terminus for detection of cell-surface expression. The C124A and C202A mutations, located near the exofacial end of transmembrane helix 3 and in EL2, respectively, ablated phospholipase C stimulation by </=100 microM 2-MeSADP. Surface enzyme-linked immunosorbent assay detection of both mutant receptors showed <10% expression, suggesting that a critical disulfide bridge between EL2 and the upper part of transmembrane 3, as found in many other G protein-coupled receptors, is required for proper trafficking of the P2Y1 receptor to the cell surface. In contrast, the C42A and C296A mutant receptors (located in the N-terminal domain and EL3) were activated by 2-MeSADP, but the EC50 values were >1000-fold greater than for the wild-type receptor. The double mutant receptor C42A/C296A exhibited no additive shift in the concentration-response curve for 2-MeSADP. These data suggest that Cys42 and Cys296 form another disulfide bridge in the extracellular region, which is critical for activation. Replacement of charged amino acids produced only minor changes in receptor activation, with two remarkable exceptions. The E209A mutant receptor (EL2) exhibited a >1000-fold shift in EC50. However, if Glu209 were substituted with amino acids capable of hydrogen bonding (Asp, Gln, or Arg), the mutant receptors responded like the wild-type receptor. Arg287 in EL3 was impaired similarly to Glu209 when substituted by alanine. Substitution of Arg287 by lysine, another positively charged residue, failed to fully restore wild-type activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10329657      PMCID: PMC3449168          DOI: 10.1074/jbc.274.21.14639

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  Use of a sandwich enzyme-linked immunosorbent assay strategy to study mechanisms of G protein-coupled receptor assembly.

Authors:  J Jakubik; J Wess
Journal:  J Biol Chem       Date:  1999-01-15       Impact factor: 5.157

2.  Use of eukaryotic expression technology in the functional analysis of cloned genes.

Authors:  B R Cullen
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

3.  Role of the second extracellular loop of adenosine receptors in agonist and antagonist binding. Analysis of chimeric A1/A3 adenosine receptors.

Authors:  M E Olah; K A Jacobson; G L Stiles
Journal:  J Biol Chem       Date:  1994-10-07       Impact factor: 5.157

4.  Deoxyadenosine bisphosphate derivatives as potent antagonists at P2Y1 receptors.

Authors:  E Camaioni; J L Boyer; A Mohanram; T K Harden; K A Jacobson
Journal:  J Med Chem       Date:  1998-01-15       Impact factor: 7.446

5.  Phosphoinositide hydrolysis by guanosine 5'-[gamma-thio]triphosphate-activated phospholipase C of turkey erythrocyte membranes.

Authors:  T K Harden; P T Hawkins; L Stephens; J L Boyer; C P Downes
Journal:  Biochem J       Date:  1988-06-01       Impact factor: 3.857

6.  Role of the extracellular loops of the thyrotropin-releasing hormone receptor: evidence for an initial interaction with thyrotropin-releasing hormone.

Authors:  J H Perlman; A O Colson; R Jain; B Czyzewski; L A Cohen; R Osman; M C Gershengorn
Journal:  Biochemistry       Date:  1997-12-16       Impact factor: 3.162

7.  The peptide binding site of the substance P (NK-1) receptor localized by a photoreactive analogue of substance P: presence of a disulfide bond.

Authors:  N D Boyd; R Kage; J J Dumas; J E Krause; S E Leeman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

8.  Mutational analysis of the angiotensin II type 2 receptor: contribution of conserved extracellular amino acids.

Authors:  J N Heerding; D K Yee; S L Jacobs; S J Fluharty
Journal:  Regul Pept       Date:  1997-10-31

9.  Double tagging recombinant A1- and A2A-adenosine receptors with hexahistidine and the FLAG epitope. Development of an efficient generic protein purification procedure.

Authors:  A S Robeva; R Woodard; D R Luthin; H E Taylor; J Linden
Journal:  Biochem Pharmacol       Date:  1996-02-23       Impact factor: 5.858

10.  Identification of potent, selective P2Y-purinoceptor agonists: structure-activity relationships for 2-thioether derivatives of adenosine 5'-triphosphate.

Authors:  B Fischer; J L Boyer; C H Hoyle; A U Ziganshin; A L Brizzolara; G E Knight; J Zimmet; G Burnstock; T K Harden; K A Jacobson
Journal:  J Med Chem       Date:  1993-11-26       Impact factor: 7.446

View more
  43 in total

1.  NGF stimulation of erk phosphorylation is impaired by a point mutation in the transmembrane domain of trkA receptor.

Authors:  M Monshipouri; H Jiang; P Lazarovici
Journal:  J Mol Neurosci       Date:  2000 Feb-Apr       Impact factor: 3.444

2.  Heteromeric association creates a P2Y-like adenosine receptor.

Authors:  K Yoshioka; O Saitoh; H Nakata
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

Review 3.  Molecular recognition in P2 receptors: ligand development aided by molecular modeling and mutagenesis.

Authors:  K A Jacobson; C Hoffmann; Y C Kim; E Camaioni; E Nandanan; S Y Jang; D P Guo; X D Ji; I von Kügelgen; S Moro; A U Ziganshin; A Rychkov; B F King; S G Brown; S S Wildman; G Burnstock; J L Boyer; A Mohanram; T K Harden
Journal:  Prog Brain Res       Date:  1999       Impact factor: 2.453

Review 4.  Molecular recognition at purine and pyrimidine nucleotide (P2) receptors.

Authors:  Kenneth A Jacobson; Stefano Costanzi; Michihiro Ohno; Bhalchandra V Joshi; Pedro Besada; Bin Xu; Susanna Tchilibon
Journal:  Curr Top Med Chem       Date:  2004       Impact factor: 3.295

Review 5.  G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions.

Authors:  Kenneth A Jacobson; Ramachandran Balasubramanian; Francesca Deflorian; Zhan-Guo Gao
Journal:  Purinergic Signal       Date:  2012-02-29       Impact factor: 3.765

Review 6.  International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy.

Authors:  Maria P Abbracchio; Geoffrey Burnstock; Jean-Marie Boeynaems; Eric A Barnard; José L Boyer; Charles Kennedy; Gillian E Knight; Marta Fumagalli; Christian Gachet; Kenneth A Jacobson; Gary A Weisman
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

7.  Agonist-selective, receptor-specific interaction of human P2Y receptors with beta-arrestin-1 and -2.

Authors:  Carsten Hoffmann; Nicole Ziegler; Susanne Reiner; Cornelius Krasel; Martin J Lohse
Journal:  J Biol Chem       Date:  2008-08-14       Impact factor: 5.157

8.  Invited Lectures : Overviews Purinergic signalling: past, present and future.

Authors: 
Journal:  Purinergic Signal       Date:  2006-05-15       Impact factor: 3.765

9.  Architecture of P2Y nucleotide receptors: structural comparison based on sequence analysis, mutagenesis, and homology modeling.

Authors:  Stefano Costanzi; Liaman Mamedova; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2004-10-21       Impact factor: 7.446

10.  Molecular bases of defective signal transduction in the platelet P2Y12 receptor of a patient with congenital bleeding.

Authors:  Marco Cattaneo; Maddalena L Zighetti; Rossana Lombardi; Constantino Martinez; Anna Lecchi; Pamela B Conley; Jerry Ware; Zaverio M Ruggeri
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.